These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 27533979)
1. NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study. Schjerning Olsen AM; Fosbøl EL; Pallisgaard J; Lindhardsen J; Lock Hansen M; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):107-14. PubMed ID: 27533979 [TBL] [Abstract][Full Text] [Related]
2. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Schjerning Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Lamberts M; Bjerring Olesen J; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH Circulation; 2011 May; 123(20):2226-35. PubMed ID: 21555710 [TBL] [Abstract][Full Text] [Related]
3. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction. Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657 [TBL] [Abstract][Full Text] [Related]
4. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study. Olsen AS; McGettigan P; Gerds TA; Fosbøl EL; Olesen JB; Sindet-Pedersen C; Staerk L; Lock Hansen M; Pallisgaard JL; Køber L; Torp-Pedersen C; Gislason GH; Lamberts M Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):292-300. PubMed ID: 31742339 [TBL] [Abstract][Full Text] [Related]
5. [Comment on "Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction. A Nationwide Cohort Study]. Mimoso J Rev Port Cardiol; 2011 Jul; 30(7-8):689-90. PubMed ID: 22005315 [TBL] [Abstract][Full Text] [Related]
6. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study. Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Bjerring Olesen J; Lamberts M; Ruwald MH; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH Circulation; 2012 Oct; 126(16):1955-63. PubMed ID: 22965337 [TBL] [Abstract][Full Text] [Related]
7. Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction. Lamberts M; Fosbøl EL; Olsen AM; Hansen ML; Folke F; Kristensen SL; Olesen JB; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH Int J Cardiol; 2013 Sep; 168(2):832-7. PubMed ID: 23117013 [TBL] [Abstract][Full Text] [Related]
8. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study. Schjerning Olsen AM; Lindhardsen J; Gislason GH; McGettigan P; Hlatky MA; Fosbøl E; Køber L; Torp-Pedersen C; Lamberts M BMJ; 2015 Oct; 351():h5096. PubMed ID: 26481405 [TBL] [Abstract][Full Text] [Related]
9. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study. Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689 [TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. Schmidt M; Christiansen CF; Mehnert F; Rothman KJ; Sørensen HT BMJ; 2011 Jul; 343():d3450. PubMed ID: 21727167 [TBL] [Abstract][Full Text] [Related]
11. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. Lamberts M; Lip GY; Hansen ML; Lindhardsen J; Olesen JB; Raunsø J; Olsen AM; Andersen PK; Gerds TA; Fosbøl EL; Torp-Pedersen C; Gislason GH Ann Intern Med; 2014 Nov; 161(10):690-8. PubMed ID: 25402512 [TBL] [Abstract][Full Text] [Related]
13. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336 [TBL] [Abstract][Full Text] [Related]
14. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study. Bang CN; Gislason GH; Greve AM; Bang CA; Lilja A; Torp-Pedersen C; Andersen PK; Køber L; Devereux RB; Wachtell K J Am Heart Assoc; 2014 Jan; 3(1):e000382. PubMed ID: 24449803 [TBL] [Abstract][Full Text] [Related]
15. Association between nonsteroidal anti-inflammatory drugs and atrial fibrillation among a middle-aged population: a nationwide population-based cohort. Chuang SY; Hsu PF; Lin FJ; Huang YW; Wang GZ; Chang WC; Tsai HJ Br J Clin Pharmacol; 2018 Jun; 84(6):1290-1300. PubMed ID: 29560612 [TBL] [Abstract][Full Text] [Related]
16. Association between perioperative NSAID use and post-cardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: a nested cohort study from the AF Suppression Trials (AFIST) I, II and III. Ruffin RT; Kluger J; Baker WL; Wills SM; White CM; Coleman CI Curr Med Res Opin; 2008 Apr; 24(4):1131-6. PubMed ID: 18334081 [TBL] [Abstract][Full Text] [Related]
17. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Batra G; Svennblad B; Held C; Jernberg T; Johanson P; Wallentin L; Oldgren J Heart; 2016 Jun; 102(12):926-33. PubMed ID: 26928408 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction. Kang DO; An H; Park GU; Yum Y; Park EJ; Park Y; Jang WY; Kim W; Choi JY; Roh SY; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Choi CU J Am Coll Cardiol; 2020 Aug; 76(5):518-529. PubMed ID: 32731930 [TBL] [Abstract][Full Text] [Related]
19. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL; Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110 [TBL] [Abstract][Full Text] [Related]
20. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation. Padfield GJ; Steinberg C; Swampillai J; Qian H; Connolly SJ; Dorian P; Green MS; Humphries KH; Klein GJ; Sheldon R; Talajic M; Kerr CR Heart Rhythm; 2017 Jun; 14(6):801-807. PubMed ID: 28232263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]